2017
DOI: 10.1007/978-1-4939-7498-6_14
|View full text |Cite
|
Sign up to set email alerts
|

Ex Vivo Dual Perfusion of the Human Placenta: Disease Simulation, Therapeutic Pharmacokinetics and Analysis of Off-Target Effects

Abstract: In recent years ex vivo dual perfusion of the human placental lobule is seeing an international renaissance in its application to understanding fetal health and development. Here, we discuss the methods and uses of this technique in the evaluation of (1) vascular function, (2) transplacental clearance, (3) hemodynamic and oxygenation changes associated with pregnancy complications on placental structure and function, and (4) placental toxicology and post-perfusion evaluation of tissue architecture.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
24
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
5
2
1
1

Relationship

1
8

Authors

Journals

citations
Cited by 23 publications
(24 citation statements)
references
References 47 publications
0
24
0
Order By: Relevance
“…Perfusion has advantages over cell culture, tissue slices and explant studies due to the maintenance of villous architecture and relative IVS volume density (Brownbill et al . ). Vascularised fetoplacental and IVS perfusate flows are key features of the model in which the placental tissue maintains a higher metabolic level than in other human placental models (Hauguel et al .…”
Section: Introductionmentioning
confidence: 97%
“…Perfusion has advantages over cell culture, tissue slices and explant studies due to the maintenance of villous architecture and relative IVS volume density (Brownbill et al . ). Vascularised fetoplacental and IVS perfusate flows are key features of the model in which the placental tissue maintains a higher metabolic level than in other human placental models (Hauguel et al .…”
Section: Introductionmentioning
confidence: 97%
“…Although in vitro DNA hybridization kinetics based on some sequences have led to a set of mature theories (Dirks and Pierce, 2003, 2004; Dirks et al, 2004, 2007; SantaLucia and Hicks, 2004; Zhang and Winfree, 2009; Zadeh et al, 2011; Zhang et al, 2012, 2018a; Wolfe and Pierce, 2015; Wolfe et al, 2017), a basic theory for quantifying miRNA in vivo is still lacking, which is restricted by technologies in other related fields, such as fluorescence reconstruction (Ntziachristos and Weissleder, 2001; Dirks and Pierce, 2003; Cong and Wang, 2005; Lasser et al, 2008; Zhang et al, 2015; Shibata et al, 2017), pharmacokinetics (Brownbill et al, 2018; Caro et al, 2018; Sharma et al, 2018), and others. To quantify miRNA in vivo , the in vitro reaction kinetics of SQ, FP, and the target miRNA must be accurately modeled mathematically.…”
Section: Resultsmentioning
confidence: 99%
“…A number of publications have addressed placental EVs and their potential role in pregnancy and its complications . Several ex vivo (eg, placental perfusion) and in vivo systems have been used as a source of EVs. Placental perfusion is a useful method for obtaining large numbers of EVs directly from the placenta; however, this technique is suitable only for a short period of time (2‐6 hours) after delivery .…”
Section: Discussionmentioning
confidence: 99%